Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine or steroid withdrawal after de novo kidney transplantation
2007-005844-26Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- Apr 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in kidney transplant comparing Myfortic + Certican + steroids with Myfortic + Neoral (2 arms). Primary endpoint: Graft function at 1 year. Started Apr 2008; status: completed.
02
Drugs
everolimusmycophenolate sodiumcyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2007-005844-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005844-26.